安捷伦科技发布新盈利预测,市场表现令人失望 - medwatch.com
Agilent Technologies disappoints with new earnings forecast - medwatch.com
生物技术与制药领域的最新动态
Agilent Technologies disappoints with new earnings forecast - medwatch.com
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Nigeria
Novartis was the sole bidder in $12B deal to buy Avidity
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland - Investors in Healthcare
Agilent Technologies (A) Exceeds Q4 Revenue Expectations with St - GuruFocus
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN
The Zacks Analyst Blog Highlights Alphabet, Roche, RTX, Crawford United and C&F Financial - Nasdaq
Thermo Fisher Inaugurates Customer Experience and Bioprocess Centre’s in Hyderabad - Chemical Industry Digest
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating - TipRanks
Agilent Technology Q4 Earnings Improve, Expects 6% To 8% Revenue Growth In Q1 - Nasdaq
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com India
David Roche expects controlled market correction in next six months - The Economic Times
Agilent Technologies Inc (A) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge? - Yahoo Finance
Thermo Fisher prices €2.1 billion notes offering in two tranches - Investing.com
Thermo Fisher Scientific Subsidiary Prices EUR 2.1 Bln Senior Notes Offering - Nasdaq
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - MarketScreener
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Yahoo Finance
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Business Wire